Sanofi is back with its second pact of the day, this time announcing a licensing deal for a South Korean biotech’s antibody ...
Novartis has tapped up an AI-enabled British biotech for a $1.7 billion biobucks deal to discover new targets for ...
MoneyWeek on MSN
Should you invest in biotech?
An investor whose portfolio contains some value- or income-focused investments and some growth-oriented investments, who ...
ICON plc (NASDAQ: ICLR), a world-leading clinical research organisation, today released findings from two biotech sector surveys. The first survey focused on global biotech trends and is an update of ...
Data demonstrates the significant and sustained tumor regression achieved by the CAPTN-3 platform across two distinct tri-specific antibodies, IM1240 and IM1305, targeting different tumor antigens ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback